Clinical Trial Update: GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis [NA]

View source ↗

Summary

A clinical study examining GLP-1 receptors in normal skin and psoriasis-affected skin, including observations on psoriasis outcomes with liraglutide therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: University Hospital, Gentofte, Copenhagen | Conditions: Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI | NA | Status: UNKNOWN